Great West Life Assurance Co. Can Has $24.75 Million Position in Clorox Company (The) (CLX)

Great West Life Assurance Co. Can lowered its stake in shares of Clorox Company (The) (NYSE:CLX) by 31.4% during the second quarter, according to its most recent filing with the SEC. The fund owned 185,997 shares of the company’s stock after selling 84,953 shares during the period. Great West Life Assurance Co. Can owned approximately 0.14% of Clorox Company (The) worth $24,748,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CLX. Korea Investment CORP boosted its stake in shares of Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares in the last quarter. Crossvault Capital Management LLC boosted its stake in shares of Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares in the last quarter. Destination Wealth Management boosted its stake in shares of Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after buying an additional 3,716 shares in the last quarter. Finally, Janney Capital Management LLC bought a new stake in shares of Clorox Company (The) during the first quarter valued at $216,000. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Clorox Company (CLX) opened at 134.21 on Thursday. The company has a 50 day moving average of $133.88 and a 200 day moving average of $133.46. The company has a market capitalization of $17.29 billion, a PE ratio of 26.51 and a beta of 0.40. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the previous year, the business earned $1.30 EPS. Clorox Company (The)’s revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Company will post $5.68 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Great West Life Assurance Co. Can Has $24.75 Million Position in Clorox Company (The) (CLX)” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/08/10/great-west-life-assurance-co-can-has-24-75-million-position-in-clorox-company-the-clx.html.

CLX has been the topic of several analyst reports. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price target on the stock in a research report on Monday, April 24th. Jefferies Group LLC initiated coverage on Clorox Company (The) in a research report on Tuesday, April 18th. They set a “hold” rating and a $138.00 price target on the stock. BMO Capital Markets reiterated a “buy” rating and set a $136.00 price target on shares of Clorox Company (The) in a research report on Thursday, May 4th. Finally, Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply